Bibliography
- American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161(2 Pt 1):646-64
- Lebtahi R, Moreau S, Marchand-Adam S, et al. Increased uptake of 111In-octreotide in idiopathic pulmonary fibrosis. J Nucl Med 2006;47(8):1281-7
- Borie R, Fabre A, Prost F, et al. Activation of somatostatin receptors attenuates pulmonary fibrosis. Thorax 2008;63(3):251-8
- Williams TJ, Wilson JW. Challenges in pulmonary fibrosis: 7 – Novel therapies and lung transplantation. Thorax 2008;63(3):277-84
- Thannickal VJ, Flaherty KR, Martinez FJ, Lynch JP III: Idiopathic pulmonary fibrosis: emerging concepts on pharmacotherapy. Expert Opin Pharmacother 2004;5(8):1671-86
- Demedts M, Behr J, Buhl R, et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2005;353(21):2229-42
- Bajwa EK, Ayas NT, Schulzer M, et al. Interferon-gamma1b therapy in idiopathic pulmonary fibrosis: a metaanalysis. Chest 2005;128(1):203-6
- Puente E, Saint-Laurent N, Torrisani J, et al. Transcriptional activation of mouse sst2 somatostatin receptor promoter by transforming growth factor-beta. Involvement of Smad4. J Biol Chem 2001;276(16):13461-8
- Lang A, Sakhnini E, Fidder HH, et al. Somatostatin inhibits pro-inflammatory cytokine secretion from rat hepatic stellate cells. Liver Int 2005;25(4):808-16